Division of Gastroenterology and Hepatology News
Read the latest news from Northwestern University Feinberg School of Medicine’s Department of Medicine, Division of Gastroenterology and Hepatology. The links below take you to articles where you can learn more about our faculty’s latest achievements, awards and honors.
Anti-inflammatory drugs alone are not sufficient to prevent pancreas inflammation following a common endoscopic procedure, according to a study recently published in The Lancet.
Mary Kwasny, ScD, professor of Preventive Medicine in the Division of Biostatistics, has received the American Statistical Association’s (ASA) Founders Award, the highest award the organization bestows for distinguished service.
Northwestern Medicine scientists have identified and characterized common symptoms and patterns in Eosinophilic esophagitis, according to a study published in the journal Gastroenterology, findings that will help predict how patients will respond to treatment.
Northwestern Medicine investigators have discovered a novel mechanism that regulates neutrophil recruitment into tissue during inflammation, which could be targeted to treat different inflammatory diseases and conditions, according to a recent study published in the Journal of Clinical Investigation.
Five Feinberg faculty members have been inducted into the American Society for Clinical Investigation (ASCI) and the Association of American Physicians (AAP), two of the oldest medical honor societies in the U.S.
Liver transplant recipients who met the criteria for frailty had comparatively worse quality of life after their transplant, according to a new multicenter study published in JAMA Surgery.
Northwestern Memorial Hospital was recently ranked seventh in the country for Gastroenterology & Gastrointestinal (GI) surgery by US News and World Report. This article was originally published in August 2022 Breakthroughs.
Two new treatments for Crohn’s disease showed roughly equal performance in a clinical trial.
Josh Levitsky, MD, ’08 MS, has been selected as president-elect of the American Society of Transplantation (AST).
Intensive treatment for patients with Crohn’s disease showed no safety differences compared to the current standard of care.